Wave Life Sciences Ltd.WVENASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -115.60% | +188.23% | -26.82% | -55.82% | +0.00% |
| Gross Profit Growth | -143.68% | +211.63% | -44.08% | -66.98% | +0.00% |
| EBITDA Growth | -1194.79% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | -1538.23% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | -951.90% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | -812.12% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | -818.65% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +23.98% | +47.31% | +25.73% | +26.60% | +27.61% |
| Weighted Average Shares Diluted Growth | +23.92% | +57.16% | +25.73% | +26.60% | +26.54% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -100.00% | -93.26% | +0.00% | +25.35% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +79.33% | +28.10% | +22.56% | +20.85% | -32.67% |
| Book Value per Share Growth | +0.00% | +258.90% | +438.22% | +2401.72% | -34.72% |
| Debt Growth | -19.30% | -20.90% | -22.71% | -24.81% | -27.23% |
| R&D Expense Growth | +30.20% | +31.02% | +21.45% | +7.62% | +11.35% |
| SG&A Expenses Growth | +14.58% | +18.09% | +35.49% | +25.83% | +20.24% |